Literature DB >> 12735419

Establishment of reference values for endocrine tests. III: Primary aldosteronism.

S J Baas1, E Endert, E Fliers, M F Prummel, W M Wiersinga.   

Abstract

BACKGROUND: In our laboratory well-defined reference values for the screening test and confirmation test used in the diagnosis of primary aldosteronism were lacking. In this study we established the reference-values of the plasma aldosterone concentration (PA), plasma renin activity (PRA) and PA/PRA ratio after a two-hour upright period, and of the urinary aldosterone excretion after oral sodium loading.
METHODS: Fifty healthy volunteers, equally distributed according to sex and aged between 20 and 70 years, went through the screening and confirmation test of primary aldosteronism. PA, PRA and the PA/PRA ratios were measured after a two-hour upright period (screening test). Urinary aldosterone excretion was determined in two 24-hour urine samples after an oral suppletion of 6 g NaCl a day for five days (confirmation test).
RESULTS: The following reference values were established: PA (after two-hour upright position) <0.03-1.05 nmol/l (mean: 0.47), PA/PRA ratio 0.05-0.47 (mean: 0.15) and urinary aldosterone excretion after sodium loading <3.0-47.0 nmol/24h (mean: 10.5). PRA showed a significant decrease with advancing age: median values in the 3rd to 7th decade are 3.9, 3.5, 2.5, 1.6 and 2.1 ng A1/ml/h respectively (p=0.04). PA was lower in subjects > or = 50 years old. Age did not affect the PA/PRA ratio or the urinary aldosterone excretion. There were no significant differences between the sexes in any of the above-mentioned parameters.
CONCLUSION: In this study we established reference values for the screening and confirmation test used in the diagnosis of primary aldosteronism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12735419

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  4 in total

1.  Effect of age on aldosterone/renin ratio (ARR) and comparison of screening accuracy of ARR plus elevated serum aldosterone concentration for primary aldosteronism screening in different age groups.

Authors:  Guoshu Yin; Shaoling Zhang; Li Yan; Muchao Wu; Mingtong Xu; Feng Li; Hua Cheng
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

2.  Rapid Aldosterone-Mediated Signaling in the DCT Increases Activity of the Thiazide-Sensitive NaCl Cotransporter.

Authors:  Lei Cheng; Søren Brandt Poulsen; Qi Wu; Cristina Esteva-Font; Emma T B Olesen; Li Peng; Björn Olde; L M Fredrik Leeb-Lundberg; Trairak Pisitkun; Timo Rieg; Henrik Dimke; Robert A Fenton
Journal:  J Am Soc Nephrol       Date:  2019-06-28       Impact factor: 10.121

3.  Pediatric reference intervals for aldosterone, 17alpha-hydroxyprogesterone, dehydroepiandrosterone, testosterone and 25-hydroxy vitamin D3 using tandem mass spectrometry.

Authors:  Offie P Soldin; Hirsh Sharma; Lucas Husted; Steven J Soldin
Journal:  Clin Biochem       Date:  2009-02-06       Impact factor: 3.281

Review 4.  The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension.

Authors:  Christopher H Gibbons; Peter Schmidt; Italo Biaggioni; Camille Frazier-Mills; Roy Freeman; Stuart Isaacson; Beverly Karabin; Louis Kuritzky; Mark Lew; Phillip Low; Ali Mehdirad; Satish R Raj; Steven Vernino; Horacio Kaufmann
Journal:  J Neurol       Date:  2017-01-03       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.